About

RepliCel Life Sciences Inc. (TSXV: RP) is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function such as chronic tendinosis, damaged skin and male pattern baldness.

RepliCel Life Sciences Inc. (RP.V)
Last Traded
3:58pm - 0.485
Volume
20,150
Open
0.49
Previous Close
0.49
Bid
0.46
Ask
0.51
Bid Size
N/A
Ask Size
N/A
Market Cap
9.02M
Shares Owned
N/A
Peg Ratio
0.000
Dividend Yield
N/A
Events & Conferences